About CSL Behring

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.

Today, CSL – including our businesses, CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

See our community guidelines: https://bit.ly/3Bs17Ra

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
45 Poplar Rd, Melbourne, VIC 3052, AU
description icon
Founded
1916
description icon
Keywords
Biotechnology, Complex Biologicals, Plasma And Plasma Derived Therapeutics, Vaccines

CSL Behring Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about CSL Behring

Who is the CEO of CSL?

Sabir Momluk is the CEO of CSL. To contact Sabir Momluk email at [email protected] or [email protected].

Who are the decision makers in CSL?

The decision makers in CSL are Carlos Valenzuela, Dexter Rodriguez, Dominic Amuzu, etc. Click to Find CSL decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more